AstraZeneca resumes Covid-19 vaccine trial after UK green light


LONDON: Drugs giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company said in a statement.





READ SOURCE

READ  Not too late to bet on consumer stocks: advisor

LEAVE A REPLY

Please enter your comment!
Please enter your name here